Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma

Table 2 Outcomes and adverse events of endoscopic debulking resection and chemoradiotherapy

Procedure details and outcomes of EdR
Technical success, n (%)
Success	41 (100)
Failure	0 (0)
R0 resection, n (%)
Yes	10 (24.4)
No	31 (75.6)
Procedure time [mean ± SD (range), min]	65 ± 29 (25-150)
Intraoperative complications, n (%)
Mild subcutaneous emphysema	1 (2.4)
None	40 (97.6)
Post-operative complications, n (%)
Delayed bleeding	2 (4.9)
Esophageal stenosis	19 (46.3)
Tracheoesophageal fistula	2 (4.9)
None	18 (43.9)
Complications of CRT after EdR, n (%)
Myelosuppression	7 (25)
Radiation pneumonia	3 (10.7)
Mucous toxicity	3 (10.7)
None	15 (53.6)
Follow-up period [median (range), mo]	36 (1-83)

CRT: Chemoradiotherapy; EdR: Endoscopic debulking resection.